首页> 美国卫生研究院文献>other >Systematic Review and Meta-Analysis of Pharmacological Treatment of the Symptoms of Attention-Deficit/Hyperactivity Disorder in Children with Pervasive Developmental Disorders
【2h】

Systematic Review and Meta-Analysis of Pharmacological Treatment of the Symptoms of Attention-Deficit/Hyperactivity Disorder in Children with Pervasive Developmental Disorders

机译:普遍性发育障碍儿童的注意缺陷/多动障碍症状的系统评价和药物治疗的荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Many children with pervasive developmental disorders (PDD) exhibit behaviors and symptoms of attention-deficit/hyperactivity disorder (ADHD). We sought to determine the relative efficacy of medications for treating ADHD symptoms in children with PDD by identifying all double-blind, randomized, placebo-controlled trials examining the efficacy of medications for treating ADHD symptoms in children with PDD. We located seven trials involving 225 children. A random effects meta-analysis of four methylphenidate trials showed methylphenidate to be effective for treating ADHD symptoms in children with PDD (ES = .67). Several adverse events were greater for children were taking methylphenidate compared to placebo. An individual trial of clonidine and two trials of atomoxetine suggest these agents may also be effective in treating ADHD symptoms in children with PDD.
机译:许多患有普遍性发育障碍(PDD)的儿童表现出注意力不足/多动症(ADHD)的行为和症状。我们试图通过确定所有双盲,随机,安慰剂对照试验来确定治疗PDD儿童ADHD症状的药物的相对功效,以检查该药物治疗PDD儿童ADHD症状的功效。我们找到了225名儿童的7个试验。一项对四个哌醋甲酯试验的荟萃分析显示,哌醋甲酯可有效治疗PDD患儿ADHD症状(ES = 0.67)。与安慰剂相比,服用哌醋甲酯的儿童发生的一些不良事件更大。可乐定的一项单独试验和阿托西汀的两项试验表明,这些药物也可能有效治疗PDD儿童的ADHD症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号